BioCentury | Jun 29, 2015
Clinical News

PVT-100: Phase IIa started

...to evaluate PVT-100 in >100 patients scheduled to undergo vascular invasive surgery for carotid endarterectomy. Pivotal Therapeutics Inc....
BioCentury | Nov 24, 2014
Company News

Pivotal Therapeutics management update

Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Departed: Prakash Gowd as CFO; he is succeeded by CEO Eugene Bortoluzzi WIR Staff Cardiovascular...
BioCentury | Sep 15, 2014
Company News

Pivotal Therapeutics management update

Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Hired: Prakash Gowd as CFO; he succeeds Eugene Bortoluzzi, who remains CEO and a director WIR Staff Cardiovascular...
BioCentury | May 19, 2014
Company News

Pivotal Therapeutics board of directors update

Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Appointed: John Gebhardt as non-executive chairman; he succeeds George Jackowski, who remains CSO and a director WIR Staff Cardiovascular...
BioCentury | Mar 10, 2014
Financial News

Pivotal Therapeutics completes private placement of units

Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Date completed: 3/4/14 Type: Private placement of units Raised: C$6.1 million (US$5.5 million) Units: 6,095 Price: C$1,000 (unit) Shares outstanding prior: 79.5 million Investors: Crossover Healthcare...
BioCentury | Nov 4, 2013
Financial News

Pivotal Therapeutics completes private placement of units

Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Date completed: 10/7/13 Type: Private placement of units Raised: C$1.6 million ($1.6 million) Units: 1,649 Price: C$1,000 (unit) Investor: Crossover Healthcare Fund Note: The company raised...
BioCentury | Nov 4, 2013
Financial News

Pivotal Therapeutics completes private placement of units

Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Date completed: 10/7/13 Type: Private placement of units Raised: C$2.7 million ($2.6 million) Units: 12.5 million Price: C$0.22 (unit) Shares after offering: 91.9 million Investor: Crossover...
BioCentury | Jul 2, 2012
Financial News

Pivotal Therapeutics proposes private placement of units

Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Date announced: 6/25/12 Type: Private placement of units To be raised: Up to C$5 million ($4.9 million) Units: 22.7 million Price: C$0.22 (unit) Shares outstanding prior:...
BioCentury | Apr 9, 2012
Financial News

Pivotal Therapeutics financial update

...the symbol "PVTTF." The company will continue to trade on the Canadian National Stock Exchange. Pivotal Therapeutics Inc....
Items per page:
1 - 9 of 9
BioCentury | Jun 29, 2015
Clinical News

PVT-100: Phase IIa started

...to evaluate PVT-100 in >100 patients scheduled to undergo vascular invasive surgery for carotid endarterectomy. Pivotal Therapeutics Inc....
BioCentury | Nov 24, 2014
Company News

Pivotal Therapeutics management update

Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Departed: Prakash Gowd as CFO; he is succeeded by CEO Eugene Bortoluzzi WIR Staff Cardiovascular...
BioCentury | Sep 15, 2014
Company News

Pivotal Therapeutics management update

Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Hired: Prakash Gowd as CFO; he succeeds Eugene Bortoluzzi, who remains CEO and a director WIR Staff Cardiovascular...
BioCentury | May 19, 2014
Company News

Pivotal Therapeutics board of directors update

Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Appointed: John Gebhardt as non-executive chairman; he succeeds George Jackowski, who remains CSO and a director WIR Staff Cardiovascular...
BioCentury | Mar 10, 2014
Financial News

Pivotal Therapeutics completes private placement of units

Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Date completed: 3/4/14 Type: Private placement of units Raised: C$6.1 million (US$5.5 million) Units: 6,095 Price: C$1,000 (unit) Shares outstanding prior: 79.5 million Investors: Crossover Healthcare...
BioCentury | Nov 4, 2013
Financial News

Pivotal Therapeutics completes private placement of units

Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Date completed: 10/7/13 Type: Private placement of units Raised: C$1.6 million ($1.6 million) Units: 1,649 Price: C$1,000 (unit) Investor: Crossover Healthcare Fund Note: The company raised...
BioCentury | Nov 4, 2013
Financial News

Pivotal Therapeutics completes private placement of units

Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Date completed: 10/7/13 Type: Private placement of units Raised: C$2.7 million ($2.6 million) Units: 12.5 million Price: C$0.22 (unit) Shares after offering: 91.9 million Investor: Crossover...
BioCentury | Jul 2, 2012
Financial News

Pivotal Therapeutics proposes private placement of units

Pivotal Therapeutics Inc. (CNSX:PVO; OTCQX:PVTTF), Woodbridge, Ontario Business: Cardiovascular Date announced: 6/25/12 Type: Private placement of units To be raised: Up to C$5 million ($4.9 million) Units: 22.7 million Price: C$0.22 (unit) Shares outstanding prior:...
BioCentury | Apr 9, 2012
Financial News

Pivotal Therapeutics financial update

...the symbol "PVTTF." The company will continue to trade on the Canadian National Stock Exchange. Pivotal Therapeutics Inc....
Items per page:
1 - 9 of 9